Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Patients with pernicious anemia history, intrinsic factor antibodies, or atrophic gastritis face heightened deficiency risk
doi:jamapediatrics.2025.3243
Conclusion AOMs have the potential to significantly improve population mortality and disease incidence rates
Application of this validated method successfully characterized the pharmacokinetics of tirzepatide in rats following intravenous and subcutaneous administration, demonstrating multi-exponential disposition, dose-proportional kinetics, and favorable bioavailability
With headlines often painting an alarming picture, Guy provides a clear, evidence-based overview of the real risks, the role of gallstones, and why GLP-1 therapies remain a safe and powerful tool in managing obesity and type 2 diabetes
Parker LJ, Ciccone S, Italiano LC, Primavera A, Oakley AJ, Morton CJ, et al
US$ 29.32
US$ 22.68
US$ 20.81
US$ 25.16
US$ 22.74
